Capricor Therapeutics (CAPR) Return on Capital Employed Growth (3y) (2014 - 2026)
Capricor Therapeutics (CAPR) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Capricor Therapeutics |
1.53 Bn |
1.26 Bn |
- |
16,340.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
16,340.00 |
| Dec 31, 2025 |
5,182.00 |
| Sep 30, 2025 |
3,373.00 |
| Jun 30, 2025 |
2,749.00 |
| Mar 31, 2025 |
4,424.00 |
| Dec 31, 2024 |
4,731.00 |
| Sep 30, 2024 |
-3,144.00 |
| Jun 30, 2024 |
-9,195.00 |
| Mar 31, 2024 |
-4,703.00 |
| Dec 31, 2023 |
-10,220.00 |
| Sep 30, 2023 |
-32,461.00 |
| Jun 30, 2023 |
-16,955.00 |
| Mar 31, 2023 |
-13,839.00 |
| Dec 31, 2022 |
-1,468.00 |
| Sep 30, 2022 |
5,839.00 |
| Jun 30, 2022 |
12,759.00 |
| Mar 31, 2022 |
13,021.00 |
| Dec 31, 2021 |
10,662.00 |
| Sep 30, 2021 |
8,554.00 |
| Jun 30, 2021 |
5,414.00 |
